You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The partners will provide complex oncology genomic testing, core central laboratory analysis, project and data management, and sample logistics.
The company's stock failed to meet the exchange's $1 minimum bid requirement.
Over the next two years, Cancer Genetics' genomic laboratory in Hyderabad, India, expects to analyze several thousand samples provided by ReproCell.
An increase in test order volume was offset by lower reimbursement from both Medicare and third-party payors.
Revenue from SelectOne clinical trials services and acquisitions drove the year over year growth.
Once an oncologist decides a patient needs chemotherapy, Moffitt will test for PGx markers that might hinder his or her ability to metabolize anti-vomiting and pain meds.
The partners will study the association between genetic variants and chemotherapy side effects to find biomarkers for an upcoming NGS pharmacogenomics panel.
The conditional licensure is the latest for the firm's FISH-based HPV-Associated test for cervical cancer.
The company borrowed $2 million pursuant to an amendment to a $12 million credit agreement. It also said that it has until June 19 to meet certain listing requirements.
About 19 million ACPN members will now have access to Cancer Genetics' cancer diagnostic services through their insurers.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.